CBIO Trade on Dec 20, 2019 11:27 from beno: Tradervue User Stock Trades.

Gravatar

Shared by
beno

 

Fundamentals

N/a

Catalysts / News / Painting the picture

-Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
-2018 S-3 for $200m / none of it used so far

Technical Analysis

-Levels: 6.7, 7.1, 7.50, 8.20
-Swing neck line: 7.10
-Swing Death line: 6
-Setting up for nice POC relief trade if it gaps down on Monday

Original Plan / Strategy

First Test long of 7.40

Review

Decided to cut trade early as it wasn't bouncing. ended up trading lower to 7.30 but then bouncing almost 30c. The First bounce actually would have hit my target fantasy orders but I cut it before I got filled due to weakness on the tape.


Execution detail:

Date/time Symbol Side Price Position
2019-12-20 11:27:13 CBIO buy $7.440 long
2019-12-20 11:27:13 CBIO buy $7.420 long
2019-12-20 11:28:04 CBIO sell $7.450 0


Leave a comment about this trade!

You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes just a few seconds to sign up, and it's free!

View plans, Sign up for free, or Log in